(Q51054202)

27 March 2018

title

Lipid abnormalities in chronic uremic patients. Response to treatment with gemfibrozil. (English)

1 reference

27 March 2018

0 references

Elisaf MS

1

1 reference

27 March 2018

Dardamanis MA

series ordinal

2

1 reference

27 March 2018

Papagalanis ND

series ordinal

3

1 reference

27 March 2018

Siamopoulos KC

series ordinal

4

1 reference

27 March 2018

publication date

1 January 1993

1 reference

27 March 2018

Scandinavian Journal of Urology and Nephrology

published in

1 reference

27 March 2018

volume

27

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

101-108

1 reference

27 March 2018

Lipid abnormalities in renal disease

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Plasma High-Density Lipoprotein Concentrations in Chronic-Hemodialysis and Renal-Transplant Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Prevalence of serum lipid abnormalities in chronic hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Lipid abnormalities in uremia, dialysis, and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Treatment of hyperlipidaemia in patients on chronic haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on Hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Management of hyperlipidemia of kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Deaths from Occlusive Arterial Disease in Renal Allograft Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Lipid and lipoprotein levels in undialyzed patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Defective high-density lipoprotein composition in patients on chronic hemodialysis. A possible mechanism for accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Response of plasma triglycerides to dietary change in patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

Interruption of long-term lipid-lowering treatment with bezafibrate in hypertriglyceridaemic patients. Effects on lipoprotein composition, lipase activities and the plasma lipid fatty acid spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365599309180423

10.3109/00365599309180423

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018